header
Image from OpenLibrary

Hepatoprotective efficacy and safety of ursodeoxycholic acid in pediatric cancer patients treated with chemotherapy / Mojeb Mohamed Saif Alnahari ; Supervised Manal Hamdy Elsayed , Samar Farghali Farid , Sahar Ahmed Khalil

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mojeb Mohamed Saif Abdallah Alnahari , 2013Description: 104 P. : charts ; 25cmOther title:
  • فعالية الحماية الكبدية والامان لحمض الارثودوكسيكوليك في مرضى سرطان الاطفال المعالجين كيميائيا [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacognosy Summary: Pediatric cancer are relatively common in Egypt contributing to about 10% of all cancer patients, and the most cancer type is acute lymphoblastic leukemia (ALL), accounting for approximately 30% of all malignancies in children. With chemotherapy, 95% of children with ALL achieve complete remission and over 70% are long-term surivors. Unfortunately, many of the chemotherapeutic agents used in the treatment of ALL are known to be hepatotoxic
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2013.Mo.H (Browse shelf(Opens below)) Not for loan 01010110060587000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.08.08.M.Sc.2013.Mo.H (Browse shelf(Opens below)) 60587.CD Not for loan 01020110060587000

Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacognosy

Pediatric cancer are relatively common in Egypt contributing to about 10% of all cancer patients, and the most cancer type is acute lymphoblastic leukemia (ALL), accounting for approximately 30% of all malignancies in children. With chemotherapy, 95% of children with ALL achieve complete remission and over 70% are long-term surivors. Unfortunately, many of the chemotherapeutic agents used in the treatment of ALL are known to be hepatotoxic

Issued also as CD

There are no comments on this title.

to post a comment.